Alpha-glycerophosphoric acid clinical trials
Its developmentBy Baxter Healthcare, step by step2 company-led studies, furthest phase 1: when each phase was reached, its deals, target and what is ahead.- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How each study uses alpha-glycerophosphoric acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 25 Aug 2014 · KABIVEN IN PLASTIC CONTAINER · NDA 200656 (FDA, Drugs@FDA; in a combination)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Sodium Glycerophosphate Injection
- 2
Studies by the year they started
3 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Baxter Healthcare Corporation (2) · Ain Shams University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses alpha-glycerophosphoric acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%ECompletedPhase 1Baxter Healthcare CorporationNCT06842134Written as Sodium Glycerophosphate InjectionHow we know
- A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)CompletedPhase 1Baxter Healthcare CorporationNCT06842121Written as Sodium Glycerophosphate InjectionHow we know
- Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICUStatus unknownPhase 4Ain Shams UniversityNCT04519762Written as Glycophos (Sodium Glycerophosphate)How we know
As the comparator · 1 — what is tested is compared with alpha-glycerophosphoric acid
Codes
What other systems call alpha-glycerophosphoric acid · ClinicalTrials.gg INT002897
- MeSH (NLM) C029620alpha-glycerophosphoric acidConfirmed ClinicalTrials.gov, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C029620 | alpha-glycerophosphoric acid | Confirmed ClinicalTrials.gov, NLM |
Also registered as sodium glycerophosphate (UNII RCS9EQ01V4 · RxNorm 1595589).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.